BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31921298)

  • 1. Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry.
    Lin Y; Lin CH; Yin X; Zhu L; Yang J; Shen Y; Yang C; Chen X; Hu H; Ma Q; Shi X; Shen Y; Hu Z; Huang C; Huang X
    Front Genet; 2019; 10():1255. PubMed ID: 31921298
    [No Abstract]   [Full Text] [Related]  

  • 2. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study.
    Zhang Y; He J; Zhang Y; Li L; Tang X; Wang L; Guo J; Jin C; Tighe S; Zhang Y; Zhu Y; Zhu B
    Medicine (Baltimore); 2020 Jan; 99(3):e18809. PubMed ID: 32011487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
    Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
    Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
    Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations.
    McMillan HJ; Kernohan KD; Yeh E; Amburgey K; Boyd J; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; MacKenzie A; Chakraborty P
    Can J Neurol Sci; 2021 Jul; 48(4):504-511. PubMed ID: 33059774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg.
    Kiselev A; Maretina M; Shtykalova S; Al-Hilal H; Maslyanyuk N; Plokhih M; Serebryakova E; Frolova M; Shved N; Krylova N; Il'ina A; Freund S; Osinovskaya N; Sultanov I; Egorova A; Lobenskaya A; Koroteev A; Sosnina I; Gorelik Y; Bespalova O; Baranov V; Kogan I; Glotov A
    Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis.
    Abiusi E; Vaisfeld A; Fiori S; Novelli A; Spartano S; Faggiano MV; Giovanniello T; Angeloni A; Vento G; Santoloci R; Gigli F; D'Amico A; Costa S; Porzi A; Panella M; Ticci C; Daniotti M; Sacchini M; Boschi I; Dani C; Agostiniani R; Bertini E; Lanzone A; Lamarca G; Genuardi M; Pane M; Donati MA; Mercuri E; Tiziano FD;
    J Med Genet; 2023 Jul; 60(7):697-705. PubMed ID: 36414255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal Muscular Atrophy Type I With False Negative in Newborn Screening: A Case Report.
    Hashimoto K; Yokokawa M; Yamashita D; Yuge K; Otsubo Y
    Cureus; 2023 Jul; 15(7):e42382. PubMed ID: 37621829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of marker analysis, quantitative real-time polymerase chain reaction, and multiple ligation-dependent probe amplification to determine SMN2 copy number in patients with spinal muscular atrophy.
    Alías L; Bernal S; Barceló MJ; Also-Rallo E; Martínez-Hernández R; Rodríguez-Alvarez FJ; Hernández-Chico C; Baiget M; Tizzano EF
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):587-94. PubMed ID: 21548796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.
    Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA
    Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot Study on Newborn Screening for Spinal Muscular Atrophy.
    Fonseca H; Ribeiro D; Guimarães F; Pinto C; Marcão A; Sousa C; Carvalho I; Lopes L; Rodrigues D; Rocha H; Vilarinho L
    Endocr Metab Immune Disord Drug Targets; 2023 Sep; ():. PubMed ID: 37711122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy.
    Strunk A; Abbes A; Stuitje AR; Hettinga C; Sepers EM; Snetselaar R; Schouten J; Asselman FL; Cuppen I; Lemmink H; van der Pol WL; Engel H
    Int J Neonatal Screen; 2019 Jun; 5(2):21. PubMed ID: 33072980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Modification of a Confirmatory SMA Sequencing Assay that Can Be Used to Determine
    Kumar B; Barton S; Kordowska J; Eaton RB; Counihan AM; Hale JE; Comeau AM
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34449530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal muscular atrophy carriers with two SMN1 copies.
    Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M
    Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of homozygous deletions in spinal muscular atrophy with genomic DNA sequencing].
    Cao YY; Qu YJ; Song F; Bai JL; Jin YW; Wang H; Li Y; Zhang WH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):410-4. PubMed ID: 23926006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Frequency of
    Yalcintepe S; Karal Y; Demir S; Atli EI; Atli E; Eker D; Mail C; Zhuri D; Guler HS; Gurkan H
    Glob Med Genet; 2023 Jun; 10(2):117-122. PubMed ID: 37332684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.